1,924 findings · Energy balance · published 2022+
- Energy balanceStrong
In the study, 8.7% of participants receiving GLP-1 RA had a cardiovascular event compared to 11.2% of those receiving placebo.
The data indicates a lower incidence of cardiovascular events with GLP-1 RA treatment.
Supports 2022 - Energy balanceStrong
11% of adults aged 19-50 in the United States have habitual protein intakes below the Estimated Average Requirement (EAR) for a dietary Digestible Indispensable Amino Acid Score (DIAAS) of 100%.
Practitioners should assess protein intake adequacy in adults, particularly in the specified age group.
Supports 2024 - Energy balanceStrong
22% of adults aged 19-50 in the United States have habitual protein intakes below the Recommended Dietary Allowance (RDA).
Practitioners should ensure that adults meet the Recommended Dietary Allowance for protein.
Supports 2024 - Energy balanceStrong
Lower dietary protein quality can potentially lead to inadequate utilizable protein intakes, especially for the elderly and some vegetarians and vegans.
Practitioners should consider dietary protein quality when advising elderly individuals and those following vegetarian or vegan diets.
Supports 2024 - Energy balanceStrong
Fifteen states provide or propose to provide screening for food insecurity and referral to food security programs.
Practitioners can leverage state programs for food insecurity screening and referrals.
Supports 2024 - Energy balanceStrong
Thirteen states provide or propose to provide coverage of nutrition education services.
Practitioners should consider the availability of nutrition education services in their states.
Supports 2024 - Energy balanceStrong
There was no increased risk of IBD-specific adverse events associated with semaglutide use.
Semaglutide can be considered safe for use in IBD patients without increasing the risk of adverse events.
Supports 2024 - Energy balanceStrong
Moderate coffee consumption is not associated with increased risk of CVD.
Health professionals can reassure patients that moderate coffee intake is safe regarding CVD risk.
Supports 2025New - Energy balanceStrong
Mean total daily energy expenditure (TEE) for female soccer players was 2693 ± 432 kcal·d-1 over 12 days.
Practitioners should consider these energy expenditure values when planning nutrition for female soccer players.
Supports 2022 - Energy balanceStrong
88% of players were categorized with low energy availability (EA) status according to the threshold of <30 kcal·kg-1 FFM.
Practitioners should address energy availability to optimize player health and performance.
Supports 2022 - Energy balanceStrong
Mean daily carbohydrate intake was 3.3 ± 0.7 g·kg-1 body mass.
Practitioners should ensure adequate carbohydrate intake for optimal performance.
Supports 2022 - Energy balanceStrong
Obesity and chronic kidney disease place a significant burden on the health care delivery system.
Healthcare providers should be aware of the systemic impacts of obesity and CKD.
Supports 2024 - Energy balanceStrong
High school students in Philadelphia experienced reductions in soda consumption due to sugar-sweetened beverage taxes.
Implementing sugar-sweetened beverage taxes may effectively reduce soda consumption among adolescents.
Supports 2022 - Energy balanceStrong
Average body mass index (BMI) among high school students decreased in Philadelphia, San Francisco, and Oakland following the implementation of sugar-sweetened beverage taxes.
Sugar-sweetened beverage taxes may contribute to lower BMI in adolescents.
Supports 2022 - Energy balanceStrong
Weight loss interventions in women with breast cancer significantly reduced body weight and fat mass but also reduced lean mass.
Practitioners should be aware that while weight loss interventions can be effective, they may also lead to reductions in lean mass.
Qualifies 2022 - Energy balanceStrong
The consensus defines sarcopenic obesity with a 3-step algorithm, including screening, diagnosis, and intervention.
Practitioners can use this algorithm for diagnosing and managing sarcopenic obesity.
Supports 2025New - Energy balanceStrong
FI-E scores were relatively lower among lifestyle participants throughout follow-up.
Lifestyle interventions may be effective in reducing frailty over time.
Supports 2023 - Energy balanceStrong
Once semaglutide is stopped, people regain most of their pretreatment weight.
Practitioners should inform patients about the potential for weight regain after stopping treatment.
Refutes 2023 - Energy balanceStrong
Dietary intake of trans fatty acids, palmitic acid, stearic acid, and saturated fatty acids from meat and unprocessed meat was modestly associated with a higher risk of coronary events.
Reducing intake of certain fatty acids may be beneficial for lowering coronary event risk.
Supports 2023 - Energy balanceStrong
Bariatric surgery resulted in an overall 25.8% weight reduction, outperforming lifestyle and pharmacotherapy interventions.
Bariatric surgery may be the most effective intervention for significant weight loss in obese individuals.
Supports 2024 - Energy balanceStrong
Food is Medicine (FIM) interventions link food security, nutrition security, health, and health equity integrated into health care delivery.
Practitioners should consider integrating FIM interventions into health care to address food and nutrition security.
Supports 2024 - Energy balanceStrong
There is no one-size-fits-all approach to dietary recommendations for the management and treatment of chronic diseases such as obesity.
Practitioners should consider individualized dietary recommendations rather than a standard approach.
Supports 2023 - Energy balanceStrong
There is no single mode of physical activity that is superior for weight loss or prevention of weight gain.
Advise clients that various forms of physical activity can be effective for weight management, and they should choose what they enjoy.
Supports 2024 - Energy balanceStrong
Factors linked to greater weight loss on liraglutide include being female, not having diabetes, having relatively high baseline weight, and losing at least 4% of initial weight after 16 weeks of treatment.
Healthcare providers should consider these factors when predicting weight loss outcomes for patients on liraglutide.
Supports 2023